Arbutus Biopharma Financial Overview
Arbutus Biopharma's market cap is currently $852.00M. The company's EPS TTM is $-0.04; its P/E ratio is ―; Arbutus Biopharma is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
